Cargando…

Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?

BACKGROUND: South Africa has a large domestically funded HIV programme with highly saturated coverage levels for most prevention and treatment interventions. To further optimise its allocative efficiency, we designed a novel optimisation method and examined whether the optimal package of interventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Calvin, Johnson, Leigh F., Jamieson, Lise, Larson, Bruce A., Meyer-Rath, Gesine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282636/
https://www.ncbi.nlm.nih.gov/pubmed/28143525
http://dx.doi.org/10.1186/s12889-017-4023-3
_version_ 1782503361170374656
author Chiu, Calvin
Johnson, Leigh F.
Jamieson, Lise
Larson, Bruce A.
Meyer-Rath, Gesine
author_facet Chiu, Calvin
Johnson, Leigh F.
Jamieson, Lise
Larson, Bruce A.
Meyer-Rath, Gesine
author_sort Chiu, Calvin
collection PubMed
description BACKGROUND: South Africa has a large domestically funded HIV programme with highly saturated coverage levels for most prevention and treatment interventions. To further optimise its allocative efficiency, we designed a novel optimisation method and examined whether the optimal package of interventions changes when interaction and non-linear scale-up effects are incorporated into cost-effectiveness analysis. METHODS: The conventional league table method in cost-effectiveness analysis relies on the assumption of independence between interventions. We added methodology that allowed the simultaneous consideration of a large number of HIV interventions and their potentially diminishing marginal returns to scale. We analysed the incremental cost effectiveness ratio (ICER) of 16 HIV interventions based on a well-calibrated epidemiological model that accounted for interaction and non-linear scale-up effects, a custom cost model, and an optimisation routine that iteratively added the most cost-effective intervention onto a rolling baseline before evaluating all remaining options. We compared our results with those based on a league table. RESULTS: The rank order of interventions did not differ substantially between the two methods- in each, increasing condom availability and male medical circumcision were found to be most cost-effective, followed by anti-retroviral therapy at current guidelines. However, interventions were less cost-effective throughout when evaluated under the optimisation method, indicating substantial diminishing marginal returns, with ICERs being on average 437% higher under our optimisation routine. CONCLUSIONS: Conventional league tables may exaggerate the cost-effectiveness of interventions when programmes are implemented at scale. Accounting for interaction and non-linear scale-up effects provides more realistic estimates in highly saturated real-world settings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12889-017-4023-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5282636
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52826362017-02-03 Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered? Chiu, Calvin Johnson, Leigh F. Jamieson, Lise Larson, Bruce A. Meyer-Rath, Gesine BMC Public Health Research Article BACKGROUND: South Africa has a large domestically funded HIV programme with highly saturated coverage levels for most prevention and treatment interventions. To further optimise its allocative efficiency, we designed a novel optimisation method and examined whether the optimal package of interventions changes when interaction and non-linear scale-up effects are incorporated into cost-effectiveness analysis. METHODS: The conventional league table method in cost-effectiveness analysis relies on the assumption of independence between interventions. We added methodology that allowed the simultaneous consideration of a large number of HIV interventions and their potentially diminishing marginal returns to scale. We analysed the incremental cost effectiveness ratio (ICER) of 16 HIV interventions based on a well-calibrated epidemiological model that accounted for interaction and non-linear scale-up effects, a custom cost model, and an optimisation routine that iteratively added the most cost-effective intervention onto a rolling baseline before evaluating all remaining options. We compared our results with those based on a league table. RESULTS: The rank order of interventions did not differ substantially between the two methods- in each, increasing condom availability and male medical circumcision were found to be most cost-effective, followed by anti-retroviral therapy at current guidelines. However, interventions were less cost-effective throughout when evaluated under the optimisation method, indicating substantial diminishing marginal returns, with ICERs being on average 437% higher under our optimisation routine. CONCLUSIONS: Conventional league tables may exaggerate the cost-effectiveness of interventions when programmes are implemented at scale. Accounting for interaction and non-linear scale-up effects provides more realistic estimates in highly saturated real-world settings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12889-017-4023-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-31 /pmc/articles/PMC5282636/ /pubmed/28143525 http://dx.doi.org/10.1186/s12889-017-4023-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chiu, Calvin
Johnson, Leigh F.
Jamieson, Lise
Larson, Bruce A.
Meyer-Rath, Gesine
Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
title Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
title_full Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
title_fullStr Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
title_full_unstemmed Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
title_short Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
title_sort designing an optimal hiv programme for south africa: does the optimal package change when diminishing returns are considered?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282636/
https://www.ncbi.nlm.nih.gov/pubmed/28143525
http://dx.doi.org/10.1186/s12889-017-4023-3
work_keys_str_mv AT chiucalvin designinganoptimalhivprogrammeforsouthafricadoestheoptimalpackagechangewhendiminishingreturnsareconsidered
AT johnsonleighf designinganoptimalhivprogrammeforsouthafricadoestheoptimalpackagechangewhendiminishingreturnsareconsidered
AT jamiesonlise designinganoptimalhivprogrammeforsouthafricadoestheoptimalpackagechangewhendiminishingreturnsareconsidered
AT larsonbrucea designinganoptimalhivprogrammeforsouthafricadoestheoptimalpackagechangewhendiminishingreturnsareconsidered
AT meyerrathgesine designinganoptimalhivprogrammeforsouthafricadoestheoptimalpackagechangewhendiminishingreturnsareconsidered